The Washington Post (2/9, Cunningham) reported the White House’s Council of Economic Advisers released a 30-page paper “that promotes easing government regulations and spurring innovation to lower drug prices, while roundly rejecting the idea of government price setting.” The paper outlined several proposals concerning Medicare, Medicaid, and the Food and Drug Administration with the aim of lowering drug prices.
The New York Times (2/10, A14, Thomas, Abelson, Subscription Publication) reported that in addition to the recommendations outlined in the new paper, the President’s budget proposal, which is scheduled to be released today, is expected to address high drug costs by proposing an expansion of “drug coverage under Medicare.”
The Hill (2/9, Sullivan) reported that the proposals outlined in the White House paper “include a cap on out-of-pocket spending for enrollees in Medicare’s prescription drug program, allowing up to five states to join together to negotiate drug prices for Medicaid and cutting Medicare payments to remove an incentive for doctors to prescribe higher-priced drugs.”
Modern Healthcare (2/9, Kacik, Subscription Publication) reported the paper also “proposed decreasing concentration of pharmacy benefit managers, restricting drug-reimbursement under the 340B drug discount program and moving Medicare Part B drug coverage into Medicare Part D, among other recommendations.”
Learn more by contacting Benefit Team at (800) 248-7114